Results 211 to 220 of about 461,523 (268)
A Bioinspired Approach to Next-Generation Vaccines in Solid Tumors with Engineered Cell Membranes. [PDF]
Research (Wash D C)Zhang W, Chen M, Huang X.
europepmc +1 more source
Adapter-based allogeneic CAR T cells to overcome antigen escape in solid tumors. [PDF]
Front ImmunolPham PQ, Sodji QH.
europepmc +1 more source
Optimizing next-generation CAR-macrophages against solid tumors: challenges and potential strategies. [PDF]
J Hematol OncolChen Y +9 more
europepmc +1 more source
CAR-T cells in solid tumors: engineering, biomarkers, translational pathways and the road ahead. [PDF]
Front ImmunolAl Shaer NSH +6 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Future Oncology, 2019
One of the most attractive cancer-related genes under investigation is BAP1. Reasons of this growing interest are related to the wide spectrum of pathways directly or indirectly modulated by this gene and shared by several solid tumors. Programmed cell-death, cell metabolisms, immune cells development, ferroptosis and defects in DNA damage response are
Di Nunno V. +8 more
openaire +3 more sources
One of the most attractive cancer-related genes under investigation is BAP1. Reasons of this growing interest are related to the wide spectrum of pathways directly or indirectly modulated by this gene and shared by several solid tumors. Programmed cell-death, cell metabolisms, immune cells development, ferroptosis and defects in DNA damage response are
Di Nunno V. +8 more
openaire +3 more sources
Expert Opinion on Investigational Drugs, 2009
Until recently, few treatments were available for renal cell carcinoma (RCC) and gastrointestinal stromal tumors (GIST). Several targeted agents inhibiting key pathogenetic pathways have since been developed for RCC (sunitinib, sorafenib, bevacizumab, temsirolimus, everolimus) and GIST (imatinib, sunitinib).
Hui K, Gan +2 more
openaire +2 more sources
Until recently, few treatments were available for renal cell carcinoma (RCC) and gastrointestinal stromal tumors (GIST). Several targeted agents inhibiting key pathogenetic pathways have since been developed for RCC (sunitinib, sorafenib, bevacizumab, temsirolimus, everolimus) and GIST (imatinib, sunitinib).
Hui K, Gan +2 more
openaire +2 more sources
Medical Physics, 1993
Dosimetry data arising from a decade of radioimmunotherapy are summarized along with techniques utilized to arrive at the reported dose estimates. Generality of the MIRD methodology allows it to serve as a vehicle for the calculation of solid tumor dosimetry although several limitations exist.
R F, Meredith +7 more
openaire +2 more sources
Dosimetry data arising from a decade of radioimmunotherapy are summarized along with techniques utilized to arrive at the reported dose estimates. Generality of the MIRD methodology allows it to serve as a vehicle for the calculation of solid tumor dosimetry although several limitations exist.
R F, Meredith +7 more
openaire +2 more sources
Nursing Clinics of North America, 1994
A thorough understanding of the incidence, clinical presentation, treatment, prognosis, and psychosocial issues surrounding children with solid tumors enables the nurse to actively participate on the health care team. Although significant advances over the past two-and-a-half decades to improve the outcomes of children with cancer have occurred, there ...
J, Nemes, M C, Donahue
openaire +2 more sources
A thorough understanding of the incidence, clinical presentation, treatment, prognosis, and psychosocial issues surrounding children with solid tumors enables the nurse to actively participate on the health care team. Although significant advances over the past two-and-a-half decades to improve the outcomes of children with cancer have occurred, there ...
J, Nemes, M C, Donahue
openaire +2 more sources